Cyclophosphamide
- Product NDC
- 16714-859
- 11-digit product format
- 167140859
- Labeler code
- 16714
- Product ID
- 16714-859_27e82150-4ad3-5be6-e063-6394a90a0e3f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- cyclophosphamide
- Dosage form
- INJECTION, POWDER, FOR SOLUTION
- Route
- INTRAVENOUS; ORAL
- Labeler
- NorthStar Rx LLC
- Application
- ANDA204555
- Marketing category
- ANDA
- Marketing start
- 2019-01-08
- Substance
- CYCLOPHOSPHAMIDE
- Active strength
- 500 mg/25mL
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Cyclophosphamide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CYCLOPHOSPHAMIDE | 500 mg/25mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 8N3DW7272P |
| Rxcui | 1734917, 1734919, 1734921 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 16714-859-01 | Cyclophosphamide | 1 in 1 CARTON | INJECTION, POWDER, FOR SOLUTION | 1 | | 9 |
| 16714-859-01 | Cyclophosphamide | 25 mL in 1 VIAL, SINGLE-DOSE | INJECTION, POWDER, FOR SOLUTION | 25 | | 9 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 16714-859 | CYCLOPHOSPHAMIDE INJECTION, POWDER, FOR SOLUTION [NORTHSTAR RX LLC] | 9 | Current NDC, Legacy NDC, 2 package rows | 20241129_76f057be-e3da-0a89-e053-2a91aa0a8438.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 16714-859-01 | 16714085901 | 1 VIAL, SINGLE-DOSE in 1 CARTON (16714-859-01) / 25 mL in 1 VIAL, SINGLE-DOSE | 2019-01-08 | 0000-00-00 | No | No | Current |